Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced today the successful ...

Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal ...

National Prescription Drug Takeback Day is Saturday and there will be an event in Columbus for residents to drop off their ...

The state of South Dakota is partnering with Emily’s Hope to provide life-saving medication kits to reverse opioid overdoses.

Narcan – known generically as naloxone – is a nasal spray that works to reverse the effects of an opioid overdose in two to ...

Polyrizon (PLRZ) announced the preliminary safety study for a formulation of its PL-14 Allergy Blocker. Conducted on fully differentiated human ...

A $56 million grant to train emergency responders and supply them with the overdose reversal spray, plus other programs that ...

Peace deal: In an unusually sharp message to President Vladimir V. Putin of Russia on Thursday, President Trump called on him ...

Parents concerned about their children abusing drugs and alcohol should simply talk to them about the issue, according to ...

Penpulimab is approved for multiple indications in China, but this marks the first US approval for the novel monoclonal ...

The FDA has approved Akeso Inc.’s penpulimab-kcqx in combination with cisplatin or carboplatin and gemcitabine for the first-line treatment of adult recurrent or metastatic NPC.

Akeso Inc. scored U.S. FDA approval of the PD-1 monoclonal antibody penpulimab in combination with cisplatin or carboplatin and gemcitabine for the first-line treatment of adult recurrent or ...